Lynwood Capital Management Inc. 13D and 13G filings for BriaCell Therapeutics Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:35 pm Purchase | 2022-12-31 | 13G | BRIACELL THERAPEUTICS INC BCTX | Lynwood Capital Management Inc. | 9,733 9.300% | 3,933 (+67.81%) | Filing |
| 2022-08-01 07:00 am Purchase | 2022-07-20 | 13G | BRIACELL THERAPEUTICS INC BCTX | Lynwood Capital Management Inc. | 5,800 5.600% | 567 (+10.84%) | Filing |
| 2022-02-11 08:00 am Sale | 2021-12-31 | 13G | BRIACELL THERAPEUTICS INC BCTX | Lynwood Capital Management Inc. | 5,233 4.920% | -634 (-10.81%) | Filing |